The IBD Registry in conjunction with Dovetail took home the Agility and Flexibility award at last week’s Communiqué Awards, held at the Grosvenor House in London.
The entry focused on a patient-friendly self-assessment risk tool to reassure patients with inflammatory bowel disease (IBD) and support hospital IBD teams at the start of the COVID-19 shielding programme.
The judges said they were “impressed with the rapid and robust strategic response and how Dovetail and IBD Registry’s collaborative nature showed a huge degree of flexibility”.
Dovetail Managing Director Claire Munro added:
“We’re delighted to win the first-ever Communiqué award for agility and flexibility, with our long-standing client, the IBD Registry, especially in the company of such an impressive list of finalists.
The COVID-19 patient self-assessment risk tool was created in just eight days. It succeeded because the IBD community pulled together, adapted to uniquely challenging circumstances, and designed a joint solution that supported people with IBD and the clinical teams that look after them. This collaborative approach is fundamental to Dovetail’s ethos and enabled us to rapidly align and coordinate the multiple stakeholder communications needed for a successful launch.
The tool was designed to inform and reassure people with IBD, while easing the burden on hard-pressed clinicians at the height of the pandemic’s first wave. As a model for future ways of working, it shows how patients can partner with clinical teams in managing long term conditions.
The Dovetail team is incredibly proud to have contributed to this worthwhile initiative.”
Find out more about how the IBD Registry collects and analyses data to improve the health of people living with inflammatory bowel disease here.
Find out more about Dovetail and our mission to transform healthcare hand in hand here.